Cambridge Investment Research Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,311
Closed -$213K 3220
2023
Q2
$213K Sell
2,311
-99
-4% -$9.13K ﹤0.01% 2822
2023
Q1
$250K Buy
+2,410
New +$250K ﹤0.01% 2643
2022
Q4
Sell
-2,607
Closed -$283K 3170
2022
Q3
$283K Buy
2,607
+305
+13% +$33.1K ﹤0.01% 2409
2022
Q2
$416K Buy
2,302
+814
+55% +$147K ﹤0.01% 2104
2022
Q1
$254K Buy
1,488
+64
+4% +$10.9K ﹤0.01% 2681
2021
Q4
$298K Sell
1,424
-232
-14% -$48.6K ﹤0.01% 2532
2021
Q3
$319K Buy
1,656
+329
+25% +$63.4K ﹤0.01% 2408
2021
Q2
$375K Buy
1,327
+83
+7% +$23.5K ﹤0.01% 2291
2021
Q1
$263K Buy
1,244
+83
+7% +$17.5K ﹤0.01% 2381
2020
Q4
$228K Buy
+1,161
New +$228K ﹤0.01% 2373
2020
Q1
Sell
-6,611
Closed -$724K 2405
2019
Q4
$724K Buy
6,611
+33
+0.5% +$3.61K 0.01% 1343
2019
Q3
$682K Sell
6,578
-182
-3% -$18.9K 0.01% 1298
2019
Q2
$867K Buy
6,760
+108
+2% +$13.9K 0.01% 1101
2019
Q1
$848K Sell
6,652
-443
-6% -$56.5K 0.01% 1124
2018
Q4
$887K Sell
7,095
-854
-11% -$107K 0.01% 1000
2018
Q3
$1.76M Buy
7,949
+122
+2% +$27K 0.02% 738
2018
Q2
$1.25M Buy
7,827
+319
+4% +$51.1K 0.01% 866
2018
Q1
$702K Buy
7,508
+1,701
+29% +$159K 0.01% 1136
2017
Q4
$405K Sell
5,807
-106
-2% -$7.39K ﹤0.01% 1444
2017
Q3
$351K Buy
5,913
+741
+14% +$44K ﹤0.01% 1466
2017
Q2
$214K Sell
5,172
-1
-0% -$41 ﹤0.01% 1713
2017
Q1
$230K Buy
5,173
+91
+2% +$4.05K ﹤0.01% 1541
2016
Q4
$212K Buy
+5,082
New +$212K ﹤0.01% 1471